Activate Your ONFI Savings Right Now!
- Start your FREE 14-Day Trial
- Save on your prescription copay
*Medicaid patients and other federal health care program beneficiaries, patients who are self-pay, and patients who do not have insurance coverage for ONFI are not eligible. Eligible commercial patients must be at least 2 years old to participate. See complete Terms and Conditions below.
Terms and Conditions for the ONFI 14-Day Free Trial and Copay Assistance ProgramsGeneral Terms and Conditions: Only commercially insured patients age 2 and older whose insurance policy provides coverage for ONFI® (clobazam) and who are not reimbursed for the entire cost of the prescription are eligible for the 14-day free trial voucher or copay assistance (the "Offers"). Patients are not eligible for the Offers if they are self-pay or if the prescription is eligible to be reimbursed, in whole or in part, by any state or federal health care programs, including but not limited to Medicare or Medicaid, Medigap, VA, DOD, or TRICARE. In addition, patients may not use the Offers if they are Medicare-eligible and enrolled in an employer-sponsored health plan or prescription drug benefit program for retirees. Offers are valid only for use with a valid prescription for ONFI at the time the prescription is filled by the pharmacist and dispensed to the patient. Offers apply only to prescriptions filled before the programs expire. The free trial and copay prescriptions shall not be submitted for reimbursement to any public third‑party payer, including Medicaid or Medicare or any other similar federal or state healthcare program; in addition, the free trial prescription shall not be submitted to any private third-party payer. Patients are responsible for complying with any obligations or requirements imposed by their insurance plans. The Offers are not transferable. The selling, purchasing, trading, or counterfeiting of the Offers is prohibited by law. The Offers have no cash value and may not be used in combination with any other discount, coupon, rebate, free trial, or similar offer for the specified prescription. Lundbeck reserves the right to rescind, revoke, or amend the Offers without notice. Offers are intended to comply with all applicable laws and regulations, including, without limitation, the federal Anti-Kickback Statute, its implementing regulations, and related guidance interpreting the federal Anti-Kickback Statute. Offers are not health insurance. Offers are valid only in the USA where allowed by law. There is no future purchase requirement associated with the Offers. Patient questions and requests to discontinue participation in the programs can be directed to 1‑855‑809‑5818 (8:00 am‑8:00 pm ET, Monday through Friday).
14-Day Free Trial Terms and Conditions: To participate in this program, eligible commercially insured patients age 2 and older must present the 14-day free trial voucher to the pharmacist along with their valid prescription. By participating in the 14-Day Free Trial, the patient acknowledges and agrees that he/she is eligible to participate and that he/she understands and agrees to comply with the General and 14-Day Free Trial Terms and Conditions.
Copay Assistance Terms and Conditions: Eligible patients must present their activated card to the pharmacist along with their valid Onfi prescription to participate in this program. The offer is valid for up to 12 prescription fills of a 30-day supply each. Use of the Copay Assistance program will require patients to pay a minimum of $10 out-of-pocket expense for each 30-day prescription. To be eligible, patients must have a copay that exceeds $10 for each 30-day prescription. A maximum benefit of $600 may apply for each 30-day prescription. If the patient's total out-of-pocket pharmacy bill exceeds the cap established by Lundbeck, the patient will be responsible for the additional balance. Patients should talk to their pharmacist to determine the maximum amount that they could pay based on their prescribed dosage and insurance benefits. By participating in the Copay Assistance program, the patient acknowledges and agrees that he/she is eligible to participate and that he/she understands and agrees to comply with the General and Copay Assistance Terms and Conditions.
To the Pharmacist:
- Submit transaction to McKesson Corporation using BIN #610524.
- For the copay card, if primary coverage exists, input card information as secondary coverage and transmit using the COB segment of the NCPDP transaction. Applicable discounts will be displayed in the transaction response.
- Acceptance of this card and your submission of claims are subject to the LoyaltyScript® program. Terms and Conditions posted at www.mckesson.com/mprstnc.
- For questions regarding setup, claim transmission, patient eligibility, or other issues, call the LoyaltyScript® program at 1‑855‑809‑5818 (8:00 am‑8:00 pm ET, Monday through Friday).
ONFI (clobazam) CIV is a prescription medicine used along with other medicines to treat seizures associated with Lennox-Gastaut syndrome in people 2 years of age or older.
WARNING: RISKS FROM CONCOMITANT USE WITH OPIOIDS;
ABUSE, MISUSE, AND ADDICTION; and DEPENDENCE AND WITHDRAWAL REACTIONS
See Medication Guide and full Prescribing Information for complete information.
ONFI is a benzodiazepine medicine. Taking benzodiazepines with opioid medicines, alcohol, or other central nervous system (CNS) depressants (including street drugs) can cause severe drowsiness, breathing problems (respiratory depression), coma, and death when taken with opioid medicines.
The use of benzodiazepines, including ONFI, exposes users to risks of abuse, misuse, and addiction, which can lead to overdose or death.
Stopping or decreasing ONFI dosage suddenly after continued use may cause serious withdrawal reactions, which can be life-threatening. To reduce the risk of withdrawal reactions, slowly decrease dosage to discontinue ONFI.
- Do not take ONFI if you have a known allergy to ONFI or its ingredients.
ONFI can cause risk of abuse, misuse, and addiction.
- Serious side effects including coma and death have happened in people who have abused or misused benzodiazepines, including ONFI. These serious side effects may also include delirium (severe state of confusion), paranoia, suicidal thoughts or actions, seizures, and difficulty breathing.
- You can develop an addiction even if you take ONFI as prescribed by your healthcare provider.
- Take ONFI exactly as your healthcare provider prescribed.
- Do not share your ONFI with other people AND keep ONFI in a safe place and away from children.
ONFI can cause physical dependence and withdrawal reactions.
- Do not suddenly stop taking ONFI. Stopping ONFI suddenly can cause serious and life-threatening side effects, including unusual movements, responses, or expressions, seizures, sudden and severe mental or nervous system changes, depression, seeing or hearing things that others do not see or hear, an extreme increase in activity or talking, losing touch with reality, and suicidal thoughts or actions. Call your healthcare provider or go to the nearest hospital emergency room right away if you get any of these symptoms.
- Some people who suddenly stop benzodiazepines have symptoms that can last for several weeks to more than 12 months, including anxiety, trouble remembering, learning or concentrating, depression, problems sleeping, feeling like insects are crawling under your skin, weakness, shaking, muscle twitching, burning or prickling feeling in your hands, arms, legs or feet, and ringing in your ears.
- Physical dependence is not the same as drug addiction. Talk to your healthcare provider about the differences.
- Do not take more ONFI than prescribed. Do not take ONFI for longer than prescribed.
- ONFI can make you sleepy or dizzy and slow your thinking and motor skills. This may get better over time. Do not drive, operate heavy machinery, or do other dangerous activities until you know how ONFI affects you. ONFI may cause problems with your coordination, especially when you are walking or picking things up.
- Do not drink alcohol or take other drugs that may make you sleepy or dizzy while taking ONFI without first talking to your healthcare provider. ONFI may make your sleepiness or dizziness much worse.
- Serious skin reactions have been seen when ONFI is taken with other medicines and may require stopping its use. A serious skin reaction can happen at any time during your treatment with ONFI. Call your healthcare provider immediately if you have skin blisters, rash, sores in the mouth, hives, or any other allergic reaction.
- Like other seizure medicines, ONFI may cause suicidal thoughts or actions in a very small number of people, about 1 in 500. Call your healthcare provider right away if you have any symptoms of depression, especially sudden changes in mood, behaviors, thoughts, or feelings, and especially if they are new, worse, or worry you. Stopping a seizure medicine suddenly in a patient who has epilepsy can cause seizures that will not stop.
- Tell your healthcare provider about all your medical conditions, including liver or kidney problems, lung problems (respiratory disease), depression, mood problems, or suicidal thoughts or behavior.
- If you are pregnant or plan to become pregnant, ONFI may harm your unborn baby. You and your healthcare provider will have to decide if you should take ONFI while you are pregnant.
- ONFI can pass into breast milk. You and your healthcare provider should decide if you will take ONFI or breastfeed. You should not do both.
- Tell your healthcare provider about all the medicines you take, including prescription and over-the-counter medicines, vitamins, and herbal supplements. Taking ONFI with certain other medicines can cause side effects or affect how well they work. ONFI may make your birth control medicine less effective. Talk to your healthcare provider about the best birth control method to use. Do not start or stop ONFI or other medicines without talking to your healthcare provider.
- ONFI oral suspension should be kept in its original bottle in an upright position and used within 90 days of first opening the bottle. After 90 days, safely throw away any unused ONFI oral suspension.
- The most common side effects of ONFI include: sleepiness; drooling; constipation; cough; pain with urination; fever; acting aggressive; being angry or violent; difficulty sleeping; slurred speech; tiredness; and problems with breathing.
For more information, please see the full Prescribing Information, including Boxed Warning for risks from concomitant use with opioids; abuse, misuse, and addiction; and dependence and withdrawal reactions, the ONFI Medication Guide, and Instructions For Use available at ONFI.com.
You are encouraged to report negative side effects of prescription drugs to the FDA. Visit www.fda.gov/medwatch, or call 1-800-FDA-1088.